Publication & Citation Trends
Publications
0 total
Indeterminate Data and Handling for Assessing Diagnostic Performance in Imaging Drug Developments OA
Cited by 0
Semantic Scholar
Theranostics approach in drug development: is there study efficiency when the prevalence of the molecular target is very high? OA
Cited by 4
Semantic Scholar
Comment on “Estimands for Recurrent Event Endpoints in the Presence of a Terminal Event”
Cited by 1
Semantic Scholar
Performance of LTMLE in the Presence of Missing Data in Control-Matched Longitudinal Studies
Cited by 0
Semantic Scholar
Prostate Cancer Theranostics: Concurrent Approvals by the Food and Drug Administration of the First Diagnostic Imaging Drug Indicated to Select Patients for a Paired Radioligand Therapeutic Drug OA
Cited by 12
Semantic Scholar
Bayesian Sample Size Planning Tool for Phase I Dose-Finding Trials. OA
Cited by 2
Semantic Scholar
Statement on P-values OA
Cited by 3
Semantic Scholar
Research Topics
Statistical Methods in Clinical Trials
(6)
Gene expression and cancer classification
(5)
Optimal Experimental Design Methods
(3)
Molecular Biology Techniques and Applications
(3)
Lymphoma Diagnosis and Treatment
(2)
Affiliations
National Institutes of Health
United States Food and Drug Administration
Center for Drug Evaluation and Research
Memorial Sloan Kettering Cancer Center
Zimmer Biomet (Netherlands)